Literature DB >> 29769442

Distinct biomarker signatures in HIV acute infection associate with viral dynamics and reservoir size.

Jeffrey E Teigler1,2, Louise Leyre3, Nicolas Chomont3, Bonnie Slike1,2, Ningbo Jian1,2, Michael A Eller1,2, Nittaya Phanuphak4, Eugène Kroon4, Suteeraporn Pinyakorn1,2, Leigh Anne Eller1,2, Merlin L Robb1,2, Jintanat Ananworanich1,2, Nelson L Michael1, Hendrik Streeck1,2,5, Shelly J Krebs1,2.   

Abstract

Estimating the size of the viral reservoir is critical for HIV cure strategies. Biomarkers in peripheral circulation may give insights into the establishment of the viral reservoir in compartments not easily accessible. We therefore measured systemic levels of 84 soluble biomarkers belonging to a broad array of immune pathways in acute HIV infection in both antiretroviral therapy-naive (ART-naive) individuals as well as individuals who began ART upon early detection of HIV infection. These biomarkers were measured longitudinally during acute and chronic infection and their relationship to viral reservoir establishment and persistence was assessed. We observed several distinct biomarker pathways induced following HIV infection such as IFN-γ-signaled chemokines, proinflammatory markers, and TNF-α-family members. Levels of several of these factors directly correlated with contemporaneous viral loads and/or frequency of peripheral blood mononuclear cells harboring HIV DNA during acute HIV infection. MCP-1, MIP-3β, sTNFR-II, and IL-10 levels prior to ART associated with HIV DNA levels after 96 weeks of treatment, suggesting a link between early immune signaling events and the establishment and persistence of the viral reservoir during ART. Furthermore, they offer potentially novel tools for gaining insight into relative reservoir size in acutely infected individuals and the potential of associated risks of treatment interruption.

Entities:  

Keywords:  AIDS/HIV; Chemokines; Cytokines; Inflammation

Mesh:

Substances:

Year:  2018        PMID: 29769442      PMCID: PMC6018979          DOI: 10.1172/jci.insight.98420

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  64 in total

Review 1.  Bone disease and HIV infection.

Authors:  Valerianna Amorosa; Pablo Tebas
Journal:  Clin Infect Dis       Date:  2005-11-30       Impact factor: 9.079

2.  HIV rebounds from latently infected cells, rather than from continuing low-level replication.

Authors:  Beda Joos; Marek Fischer; Herbert Kuster; Satish K Pillai; Joseph K Wong; Jürg Böni; Bernard Hirschel; Rainer Weber; Alexandra Trkola; Huldrych F Günthard
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-20       Impact factor: 11.205

3.  Elevations in IL-10, TNF-alpha, and IFN-gamma from the earliest point of HIV Type 1 infection.

Authors:  Philip J Norris; Brandee L Pappalardo; Brian Custer; Gerald Spotts; Frederick M Hecht; Michael P Busch
Journal:  AIDS Res Hum Retroviruses       Date:  2006-08       Impact factor: 2.205

Review 4.  Residual immune dysregulation syndrome in treated HIV infection.

Authors:  Michael M Lederman; Nicholas T Funderburg; Rafick P Sekaly; Nichole R Klatt; Peter W Hunt
Journal:  Adv Immunol       Date:  2013       Impact factor: 3.543

Review 5.  Aging of the innate immune system.

Authors:  Albert C Shaw; Samit Joshi; Hannah Greenwood; Alexander Panda; Janet M Lord
Journal:  Curr Opin Immunol       Date:  2010-08       Impact factor: 7.486

6.  Predictors of residual viremia in HIV-infected patients successfully treated with efavirenz and lamivudine plus either tenofovir or stavudine.

Authors:  Diane V Havlir; Kersten K Koelsch; Matthew C Strain; Nicolas Margot; Biao Lu; Caroline C Ignacio; Michael D Miller; Joseph K Wong
Journal:  J Infect Dis       Date:  2005-02-28       Impact factor: 5.226

7.  Plasma Cytokine Levels in Chronic Asymptomatic HIV-1 Subtype C Infection as an Indicator of Disease Progression in Botswana: A Retrospective Case Control Study.

Authors:  Thato Iketleng; Sikhulile Moyo; Simani Gaseitsiwe; Balthazar Nyombi; Rebecca M Mitchell; Joseph Makhema; Marianna K Baum; Richard Marlink; Max Essex; Rosemary Musonda
Journal:  AIDS Res Hum Retroviruses       Date:  2015-10-21       Impact factor: 2.205

8.  Host factors associated with serologic inflammatory markers assessed using multiplex assays.

Authors:  Heather S McKay; Jay H Bream; Joseph B Margolick; Otoniel Martínez-Maza; John P Phair; Charles R Rinaldo; Alison G Abraham; Lisa P Jacobson
Journal:  Cytokine       Date:  2016-06-10       Impact factor: 3.861

Review 9.  Emerging concepts on T follicular helper cell dynamics in HIV infection.

Authors:  Franco Pissani; Hendrik Streeck
Journal:  Trends Immunol       Date:  2014-04-02       Impact factor: 16.687

10.  A plasma biomarker signature of immune activation in HIV patients on antiretroviral therapy.

Authors:  Anupa Kamat; Vikas Misra; Edana Cassol; Petronela Ancuta; Zhenyu Yan; Cheng Li; Susan Morgello; Dana Gabuzda
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240

View more
  19 in total

Review 1.  Cytokines and chemokines involved in the defense reaction against HIV-1 and hepatitis B virus: isn't it time to use a standardized nomenclature of the involved mediators?

Authors:  Lutz G Gürtler
Journal:  Virus Genes       Date:  2019-12-17       Impact factor: 2.332

2.  Individual Differences in CD4/CD8 T-Cell Ratio Trajectories and Associated Risk Profiles Modeled From Acute HIV Infection.

Authors:  Robert Paul; Kyu Cho; Jacob Bolzenius; Carlo Sacdalan; Lishomwa C Ndhlovu; Lydie Trautmann; Shelly Krebs; Somporn Tipsuk; Trevor A Crowell; Duanghathai Suttichom; Donn J Colby; Thomas A Premeaux; Nittaya Phanuphak; Phillip Chan; Eugène Kroon; Sandhya Vasan; Denise Hsu; Adam Carrico; Victor Valcour; Jintanat Ananworanich; Merlin L Robb; Julie A Ake; Somchai Sriplienchan; Serena Spudich
Journal:  Psychosom Med       Date:  2022-07-06       Impact factor: 3.864

3.  HIV Disease Dynamics and Markers of Inflammation and CNS Injury During Primary HIV Infection and Their Relationship to Cognitive Performance.

Authors:  August A Longino; Robert Paul; Yixin Wang; Javier R Lama; Peter Brandes; Eduardo Ruiz; Cecilia Correa; Sheila Keating; Serena S Spudich; Christopher Pilcher; Alyssa Vecchio; Siavash Pasalar; Rachel A Bender Ignacio; Rogelio Valdez; Sayan Dasgupta; Kevin Robertson; Ann Duerr
Journal:  J Acquir Immune Defic Syndr       Date:  2022-02-01       Impact factor: 3.771

4.  HIV Subtype and Nef-Mediated Immune Evasion Function Correlate with Viral Reservoir Size in Early-Treated Individuals.

Authors:  Fredrick H Omondi; Sandali Chandrarathna; Shariq Mujib; Chanson J Brumme; Steven W Jin; Hanwei Sudderuddin; Rachel L Miller; Asa Rahimi; Oliver Laeyendecker; Phil Bonner; Feng Yun Yue; Erika Benko; Colin M Kovacs; Mark A Brockman; Mario Ostrowski; Zabrina L Brumme
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

5.  A Phase I, Randomized, Controlled Clinical Study of CC-11050 in People Living With HIV With Suppressed Plasma Viremia on Antiretroviral Therapy (APHRODITE).

Authors:  Afroditi Boulougoura; Erin Gabriel; Elizabeth Laidlaw; Vikram Khetani; Ken Arakawa; Jeanette Higgins; Adam Rupert; Robert J Gorelick; Keith Lumbard; Alice Pau; April Poole; Angela Kibiy; Princy Kumar; Irini Sereti
Journal:  Open Forum Infect Dis       Date:  2019-06-03       Impact factor: 3.835

Review 6.  Perspectives on Non-BLT Humanized Mouse Models for Studying HIV Pathogenesis and Therapy.

Authors:  Kazutaka Terahara; Ryutaro Iwabuchi; Yasuko Tsunetsugu-Yokota
Journal:  Viruses       Date:  2021-04-28       Impact factor: 5.048

7.  Modular Approaches to Understand the Immunobiology of Human Immunodeficiency Virus Latency.

Authors:  Gideon Wolf; Nevil J Singh
Journal:  Viral Immunol       Date:  2021-02-17       Impact factor: 2.175

8.  Effect of HIV suppression on the cytokine network in blood and seminal plasma.

Authors:  Stephen A Rawlings; Felix Torres; Alan Wells; Andrea Lisco; Wendy Fitzgerald; Leonid Margolis; Sara Gianella; Christophe Vanpouille
Journal:  AIDS       Date:  2022-04-01       Impact factor: 4.632

9.  Hydroxypropyl-Beta-Cyclodextrin Reduces Inflammatory Signaling from Monocytes: Possible Implications for Suppression of HIV Chronic Immune Activation.

Authors:  Flávio Lemos Matassoli; Ihid Carneiro Leão; Bruno Braz Bezerra; Richard B Pollard; Dieter Lütjohann; James E K Hildreth; Luciana Barros de Arruda
Journal:  mSphere       Date:  2018-11-07       Impact factor: 4.389

Review 10.  Addressing an HIV cure in LMIC.

Authors:  Sherazaan D Ismail; Joshua Pankrac; Emmanuel Ndashimye; Jessica L Prodger; Melissa-Rose Abrahams; Jamie F S Mann; Andrew D Redd; Eric J Arts
Journal:  Retrovirology       Date:  2021-08-03       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.